MARKET

CDIO

CDIO

Cardio Diagnostics Holdings Inc
NASDAQ
1.860
+0.030
+1.64%
After Hours: 1.860 0 0.00% 16:10 09/04 EDT
OPEN
1.850
PREV CLOSE
1.830
HIGH
1.860
LOW
1.820
VOLUME
10.25K
TURNOVER
--
52 WEEK HIGH
7.91
52 WEEK LOW
0.9700
MARKET CAP
5.50M
P/E (TTM)
-0.6378
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CDIO last week (0824-0828)?
Weekly Report · 6d ago
Cardio Diagnostics release new edition of rural health report
TipRanks · 08/26 12:40
Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges
Barchart · 08/26 07:35
Weekly Report: what happened at CDIO last week (0817-0821)?
Weekly Report · 08/24 09:07
Cardio Diagnostics Highlights AI-Driven Cardiovascular Risk Platform
TipRanks · 08/20 12:28
Cardio Diagnostics announces official launch of in-house laboratory in Iowa
TipRanks · 08/18 12:46
Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City
Barchart · 08/18 07:35
Weekly Report: what happened at CDIO last week (0810-0814)?
Weekly Report · 08/17 09:07
More
About CDIO
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Webull offers Cardio Diagnostics Holdings Inc stock information, including NASDAQ: CDIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDIO stock methods without spending real money on the virtual paper trading platform.